GUERRIERO, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 185.238
NA - Nord America 15.950
AS - Asia 3.222
SA - Sud America 270
AF - Africa 35
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 17
Totale 204.759
Nazione #
IT - Italia 177.354
US - Stati Uniti d'America 15.855
NL - Olanda 2.143
UA - Ucraina 1.693
SG - Singapore 1.601
SE - Svezia 1.401
DE - Germania 1.345
CN - Cina 1.292
GB - Regno Unito 423
FI - Finlandia 409
BR - Brasile 230
RU - Federazione Russa 183
FR - Francia 126
CA - Canada 76
IN - India 75
VN - Vietnam 56
HK - Hong Kong 39
BE - Belgio 30
IR - Iran 25
AT - Austria 22
TR - Turchia 19
ES - Italia 18
KR - Corea 17
EU - Europa 16
AU - Australia 14
PH - Filippine 14
NZ - Nuova Zelanda 13
RO - Romania 13
AR - Argentina 12
CO - Colombia 11
IE - Irlanda 10
MX - Messico 10
ID - Indonesia 9
UZ - Uzbekistan 9
CZ - Repubblica Ceca 7
HU - Ungheria 7
MA - Marocco 7
PK - Pakistan 7
TW - Taiwan 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
EG - Egitto 6
PL - Polonia 6
IL - Israele 5
JP - Giappone 5
LK - Sri Lanka 5
LT - Lituania 5
TN - Tunisia 5
ZA - Sudafrica 5
BD - Bangladesh 4
GR - Grecia 4
MU - Mauritius 4
PE - Perù 4
PT - Portogallo 4
VE - Venezuela 4
AL - Albania 3
AZ - Azerbaigian 3
CH - Svizzera 3
CI - Costa d'Avorio 3
EC - Ecuador 3
HR - Croazia 3
IQ - Iraq 3
RS - Serbia 3
TH - Thailandia 3
CL - Cile 2
DZ - Algeria 2
GE - Georgia 2
IS - Islanda 2
KZ - Kazakistan 2
LV - Lettonia 2
MK - Macedonia 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
SA - Arabia Saudita 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
GT - Guatemala 1
IM - Isola di Man 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
OM - Oman 1
Totale 204.752
Città #
Cagliari 170.363
Uta 5.778
Fairfield 2.260
Amsterdam 2.106
Woodbridge 1.567
Ashburn 1.153
Boardman 1.132
Houston 1.103
Chandler 1.095
Wilmington 927
Seattle 926
Ann Arbor 919
Jacksonville 902
Nyköping 862
Cambridge 781
Singapore 621
Boston 272
Dearborn 263
Nanjing 259
Santa Clara 179
Helsinki 160
Beijing 144
San Diego 137
Milan 134
Nanchang 91
Shanghai 84
Changsha 77
Shenyang 77
Guangzhou 74
Rome 67
Jiaxing 66
New York 65
Los Angeles 61
Toronto 61
Verona 60
Hebei 59
London 53
Dong Ket 50
Redwood City 47
Norwalk 46
Sassari 46
Tianjin 42
Orange 40
Hong Kong 38
Mountain View 36
San Mateo 36
Falls Church 35
Pune 35
Ningbo 32
Washington 32
Jinan 30
The Dalles 30
Auburn Hills 27
Brussels 27
Zhengzhou 26
Council Bluffs 24
Nuremberg 22
Augusta 19
Hefei 18
Chicago 16
Kunming 16
Redmond 16
Leawood 15
Saint Petersburg 15
Ardabil 14
Borås 14
Wuhan 14
Millbury 13
Monmouth Junction 13
Taizhou 13
Bologna 11
Naples 11
Torino 11
Chiswick 10
Frankfurt am Main 10
Hangzhou 10
Mumbai 10
Quartu Sant'elena 10
New Bedfont 9
São Paulo 9
Munich 8
Seoul 8
Sydney 8
Tashkent 8
Vienna 8
Budapest 7
Newark 7
Paris 7
Walnut 7
Catania 6
Dublin 6
Genoa 6
Rio de Janeiro 6
Rockville 6
Sofia 6
Villacidro 6
Yellow Springs 6
Yiwu 6
Barcelona 5
Belo Horizonte 5
Totale 196.068
Nome #
Overview of elagolix for the treatment of endometriosis 3.455
Three-dimensional ultrasonography in the diagnosis of deep endometriosis 3.185
Accuracy of transvaginal ultrasound for diagnosis of deep endometriosis in uterosacral ligaments, rectovaginal septum, vagina and bladder: systematic review and meta-analysis. 2.768
Accuracy of transvaginal ultrasound for diagnosis of deep endometriosis in the rectosigmoid: systematic review and meta-analysis 2.632
Placental growth factor and preterm delivery 2.103
Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment 2.013
Deep Infiltrating Endometriosis: Comparison Between 2-Dimensional Ultrasonography (US), 3-Dimensional US, and Magnetic Resonance Imaging 2.006
Transvaginal ultrasound (TVS) versus Magnetic Resonance (MR) for diagnosing deep infiltrating endometriosis: a systematic review and meta-analysis 1.987
Learning curve for ultrasonographic diagnosis of deep infiltrating endometriosis using structured offline training program 1.958
OC15.07: Ultrasonographic “soft” markers for the detection of rectosigmoid endometriosis 1.918
OC04.04: Is the introduction of magnetic resonance in the diagnostic workout of adnexal masses just an increase of costs when IOTA Simple Rules are applied? 1.887
Does the clinical information play a role in the magnetic resonance diagnostic confidence analysis of ovarian and deep endometriosis? 1.885
Ultrasonographic soft markers for detection of rectosigmoid deep endometriosis 1.880
Screening e diagnosi del Diabete Gestazionale in Sardegna: risultati a confronto. 1.847
Past, present and future ultrasonographic techniques for analyzing ovarian masses 1.819
Fattore di Crescita Placentare (PlGF): correlazioni con la funzione placentare 1.677
Investigational drugs for the treatment of endometriosis, an update on recent developments 1.668
Diagnostic confidence analysis in the magnetic resonance imaging of ovarian and deep endometriosis: comparison with surgical results 1.630
ADDITIONAL VALUE OF CA-125 TO ULTRASOUND FOR PREDICTING SPECIFIC DIAGNOSIS OF BENIGN ADNEXAL CYSTS IN PREMENOPAUSAL 1.622
Tissue characterization using mean gray value analysis in deep infiltrating endometriosis 1.616
Endometriosis: the role of magnetic resonance imaging 1.485
Ultrasound features of rare primary malignant ovarian tumors 1.471
Diagnostic performance of transvaginal power Doppler ultrasound for predicting malignancy of adnexsal masses in in symptomatic and asymptomatic women 1.461
OC24: The role of magnetic resonance imaging and transvaginal ultrasonography in patients with an adnexal mass and chronic pelvic pain or infertility 1.450
Endosonographic diagnosis, pre-operative treatment and laparoscopic removal with endoscopic stapler of a rudimentary horn in a woman with unicornuate uterus 1.357
Dietary composition of pregnant women in south sardinia 1.328
Influence of cryopreservation on perinatal outcome after blastocyst- vs cleavage-stage embryo transfer: systematic review and meta-analysis 1.328
Magnetic resonance imaging and transvaginal modified ulrasonography in the diagnosis of rectosigmoid endometriosis 1.276
The screening of tubal abnormalities in the infertile couple 1.267
Pattern of bone markers during pregnancy and their changes after delivery. 1.258
Ultrasound features of metastases in the ovary depending of the origin of the primary tumor 1.253
Ultrasound characteristics of endometrial cancer as defined by International Endometrial Tumor Analysis (IETA) consensus nomenclature: prospective multicenter study 1.247
Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol: observational study in young postadolescent women 1.246
Malignancy risk of sonographically benign appearing purely solid adnexal masses in asymptomatic postmenopausal women 1.213
Counting ovarian antral follicles by ultrasound: a practical guide 1.202
Two-dimensional hysterosalpingo-contrast-sonography compared to three/four-dimensional hysterosalpingo-contrast-sonography for the assessment of tubal occlusion in women with infertility/subfertility: a systematic review with meta-analysis 1.183
B-mode and Power Doppler Ultrasound in Adnexsal Masses 1.177
The Reproducibility of Ultrasonographic Findings of Rectosigmoid Endometriosis Among Examiners With Different Level of Expertise 1.161
Congenital Uterine Malformation by Experts (CUME): better criteria for distinguishing between normal/arcuate and septate uterus? 1.150
Advances in Imaging for Assessing Pelvic Endometriosis 1.142
The treatment of polycystic ovary syndrome 1.135
External validation of IOTA simple descriptors and simple rules for classifying adnexal masses 1.125
Age-related differences in the sonographic characteristics of endometriomas 1.112
Reproducibility of the International Endometrial Analysis Group color score for assigning the amount of flow within the endometrium using stored 3-dimensional volumes 1.106
Training performance in diagnosis of congenital uterine anomalies with 3-dimensional sonography: A learning curve cumulative summation analysis 1.097
Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group 1.087
The distribution of stroma and antral follicles differs between insulin-resistance and hyperandrogenism-related polycystic ovarian syndrome 1.080
Long-term results for expectant management of ultrasonographically diagnosed benign ovarian teratomas 1.072
Transvaginal ultrasound versus magnetic resonance imaging for preoperative assessment of myometrial infiltration in patients with endometrial cancer: A systematic review and meta-analysis 1.049
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group 1.007
Extragenital endometrial stromal sarcoma arising in endometriosis 1.007
The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome 914
OC15.03: Diagnosing septate uterus using 3D ultrasound using three different classifications: an inter‐ and intraobserver agreement study 914
Non-enhanced Transvaginal Ultrasonography 899
Usefulness of 3D power Doppler angiography technique to the third step in the differential diagnosis of adnexal masses. A prospective study 897
Two-dimensional transvaginal sonography vs saline contrast sonohysterography for diagnosing endometrial polyps: systematic review and meta-analysis 885
Ovarian Tissue Characterization in Ultrasound: A Review 868
The importance of transient myometrial contractions in the diagnosis of adenomyosis and congenital uterine anomalies 854
The ovarian endometrioma: clinical setting and ultrasound findings 852
Differential Diagnosis of the most common benign ovarian cysts using transvaginal ultrasonography: Results of Sardinia-Navarra (Sa.Na.) group 851
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study 843
Ultrasonography and atypical sites of endometriosis 835
Efficacy and safety of oral and transdermal hormonal replacement treatment containing levonorgestrel. 834
Prevalence of deep endometriosis in patients of a second level ultrasound laboratory and tissue US characterization of nodules using VOCAL 829
Transvaginal color Doppler in the detection of ovarian cancer in a large study population of postmenopausal women 826
Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group 826
MDCT Angiography of the anterior spinal artery 821
Imaging in gynecological disease (17): ultrasound features of malignant ovarian yolk sac tumors (endodermal sinus tumors) 815
Imaging in gynecological disease (9): clinical and ultrasound characteristics of tubal cancer 802
VP61.02: ROMA index versus ultrasound expert evaluation for detecting malignancy in adnexal masses classified as inconclusive by IOTA Simple Rules 802
Hyperinsulinemia and uterine perfusion in patients with polycystic ovary syndrome 794
Congenital Uterine Malformation by Experts (CUME): diagnostic criteria for T-shaped uterus 778
Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study 764
Intensive training program for ultrasound diagnosis of adnexal masses: protocol and preliminary results. 752
Expectant management of adnexal masses in selected premenopausal women: a prospective observational study. 751
Three-dimensional sonography for diagnosis of rectovaginal septum endometriosis: interobserver agreement 750
Imaging in gynecological disease (20): clinical and ultrasound characteristics of adnexal torsion 749
Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome 748
VP63.04: Non‐expert interobserver agreement for sonographic diagnosis of adenomyosis 741
Caratteristiche cliniche, endocrine, e metaboliche di donne non obese affette da sindrome dell'ovaio policistico (PCOS) dopo sei cicli di trattamento con la formulazione contraccettiva estroprogestinica orale monofasica contenente 30 mcg di etinilestradiolo (EE) e 2 mg di clormadinone acetato (CMA) 740
IOTA simple rules for discriminating between benign and malignant adnexal masses: prospective external validation. 717
OC19.04: Soft markers as a first line ultrasonographic tool to raise suspicion of uterosacral involvement in women suspected of having deep endometriosis 714
Sonohistology: the use simple findings to predct the histological diagnosis in more than 900 adnexal masses evaluated by single center 699
Transvaginal color Doppler in the detection of ovarian cancer in a large study population: Results of Sardinia-Navarra (Sa.Na.) group 694
VP61.01: MRI versus ultrasound expert evaluation for detecting malignancy in adnexal masses classified as inconclusive by IOTA Simple Rules 686
Imaging for Endometriosis in Adolescents 685
OC19.04: Diagnostic value of transvaginal ultrasonography for the prediction of parametrial endometriosis 684
Vessel morphology depicted by three-dimensional power Doppler ultrasound as a second stage test in difficult adnexal tumors: a prospective diagnostic accuracy study 669
Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa’ italiana di Ginecologia E Ostetricia) 661
Ovarian tumor characterization and classification using ultrasound-a new online paradigm. 659
Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies 659
Role of imaging in the management of endometriosis 641
Ultrasound in the Diagnosis of Deep Endometriosis 635
Differential diagnosis of endometriosis by ultrasound: A rising challenge 632
VP62.15: The absence of endometrioma doesn't mean absence of deep endometriosis: a new challenge 625
VP66.03: Transvaginal ultrasound colour Doppler in early diagnosis of ovarian cancer: a 20‐year experience 619
Diagnostic accuracy of transvaginal sonography for detecting parametrial involvement in women with deep endometriosis: systematic review and meta-analysis 607
Influence of vaginal danazol on uterine and brain perfusion during hormonal replacement therapy 603
Imaging in gynecological disease (13): Clinical and ultrasound characteristics of endometrioid ovarian cancer 603
VP62.13: Ultrasonographic soft markers as a first‐line tool to raise suspicion of forniceal involvement in women suspected of having deep endometriosis 603
Totale 115.917
Categoria #
all - tutte 307.143
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 307.143


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.390 0 0 0 0 0 0 0 0 0 611 840 939
2020/202138.724 1.425 1.374 1.572 9.320 8.479 4.434 4.735 2.197 710 1.626 1.615 1.237
2021/202213.172 1.412 1.022 689 987 1.250 962 875 697 1.185 1.059 1.447 1.587
2022/202322.078 1.848 2.492 2.296 1.690 1.466 1.983 1.045 3.012 1.744 1.200 2.292 1.010
2023/202425.970 1.320 1.240 1.339 2.148 2.702 4.308 4.304 1.691 1.208 1.731 2.037 1.942
2024/202539.610 5.429 8.150 6.275 5.349 2.702 2.902 5.020 357 827 2.599 0 0
Totale 205.418